Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
History
Business
Health & Fitness
Sports
About Us
Contact Us
Copyright
© 2024 PodJoint
Loading...
0:00 / 0:00
Podjoint Logo
US
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts116/v4/2d/86/a2/2d86a2ff-23b9-11b9-d4ea-137d66c689dc/mza_13723794237052728152.jpeg/600x600bb.jpg
Nucleate Singapore Pulse
Nucleate Singapore
23 episodes
3 days ago
Singapore's premier podcast on the biotech ecosystem. The show notes and transcripts can be found on nucleatesingapore.substack.com. Subscribe and follow us to keep your finger on the pulse of Singapore’s biotech ecosystem. For feedback and suggestions, feel free to reach out to the team at singapore@nucleate.org
Show more...
Life Sciences
Science
RSS
All content for Nucleate Singapore Pulse is the property of Nucleate Singapore and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Singapore's premier podcast on the biotech ecosystem. The show notes and transcripts can be found on nucleatesingapore.substack.com. Subscribe and follow us to keep your finger on the pulse of Singapore’s biotech ecosystem. For feedback and suggestions, feel free to reach out to the team at singapore@nucleate.org
Show more...
Life Sciences
Science
https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_episode/38338691/38338691-1721017939632-d09b4e276404c.jpg
Harnessing the power of antibody therapeutics with Hummingbird Bioscience’s Dr. Lisa Ooi
Nucleate Singapore Pulse
35 minutes 3 seconds
12 months ago
Harnessing the power of antibody therapeutics with Hummingbird Bioscience’s Dr. Lisa Ooi

Dr. Lisa Ooi is the Senior Vice President of Strategy at Hummingbird Bioscience, a leading biotech company in Singapore focused on antibody therapeutics. In this episode, Dr. Ooi discusses her journey from her PhD at Stanford to her current role, highlighting her experience in biomedical research and corporate strategy. She delves into Hummingbird Bioscience's innovative platform for developing antibody-based therapies, sharing insights on the company's strategic direction, the challenges of drug development, and the potential impact of their work on cancer treatment and beyond. Dr. Ooi also explores the reasons behind Hummingbird Bioscience's success in attracting investment and the unique advantages of being based in Singapore.

Host: Jessie Wong Editors: Jessie Wong, John Joson Ng

The show notes and transcripts for the episode can be found on nucleatesingapore.substack.com. For feedback or recommendations on who we should talk to next, please reach out to Joson Ng via johnjoson.n@nucleate.org.

01:00 - Introduction 10:06 - Establishing Hummingbird Bioscience in Singapore 14:22 - Innovative Antibody and ADC Development Strategy 23:37 - Revolutionizing Cancer Treatment with Dual Payload ADCs 28:56 - Hummingbird Bioscience's Role in Singapore's Biotech Ecosystem

Nucleate Singapore Pulse
Singapore's premier podcast on the biotech ecosystem. The show notes and transcripts can be found on nucleatesingapore.substack.com. Subscribe and follow us to keep your finger on the pulse of Singapore’s biotech ecosystem. For feedback and suggestions, feel free to reach out to the team at singapore@nucleate.org